AAPL315.62-0.60 (-0.19%) ▼|ABBV250.37+1.59 (+0.64%) ▲|ABT105.40-0.12 (-0.11%) ▼|ACN177.31-1.72 (-0.96%) ▼|ADBE255.49-1.78 (-0.69%) ▼|AMAT467.78-5.01 (-1.06%) ▼|AMD519.22+13.48 (+2.67%) ▲|AMGN392.11-1.07 (-0.27%) ▼|AMT175.37-0.37 (-0.21%) ▼|AMZN252.15-4.83 (-1.88%) ▼|AVGO363.76-4.81 (-1.30%) ▼|AXP322.54-3.57 (-1.09%) ▼|BA208.00-2.73 (-1.30%) ▼|BAC62.90+0.51 (+0.81%) ▲|BKNG173.08-7.23 (-4.01%) ▼|BLK1,075.34-20.04 (-1.83%) ▼|BMY64.31-0.39 (-0.60%) ▼|BNY163.26+0.41 (+0.25%) ▲|BRK-B507.31+1.48 (+0.29%) ▲|C138.43+1.69 (+1.23%) ▲|CAT818.05-4.43 (-0.54%) ▼|CL88.02-0.39 (-0.44%) ▼|CMCSA24.56-1.77 (-6.72%) ▼|COF212.55-1.42 (-0.66%) ▼|COP137.24+2.20 (+1.63%) ▲|COST901.49-8.69 (-0.95%) ▼|CRM244.28-4.85 (-1.94%) ▼|CSCO109.28+0.11 (+0.10%) ▲|CVS95.82-0.25 (-0.26%) ▼|CVX214.01+4.21 (+2.01%) ▲|DE677.21-3.53 (-0.52%) ▼|DHR205.08-0.15 (-0.07%) ▼|DIS104.43-0.63 (-0.60%) ▼|DUK120.32-0.92 (-0.76%) ▼|EMR151.08-1.07 (-0.70%) ▼|FDX310.14-3.99 (-1.27%) ▼|GD352.72-3.87 (-1.08%) ▼|GE326.49-8.42 (-2.52%) ▼|GEV953.40-17.91 (-1.84%) ▼|GILD145.74-0.90 (-0.61%) ▼|GM84.75-1.04 (-1.21%) ▼|GOOG328.54-6.85 (-2.04%) ▼|GOOGL330.99-7.38 (-2.18%) ▼|GS1,031.66-4.87 (-0.47%) ▼|HD311.17-2.53 (-0.81%) ▼|HON205.26-2.98 (-1.43%) ▼|IBM239.46+7.37 (+3.18%) ▲|INTC106.23+1.76 (+1.68%) ▲|INTU314.34-4.59 (-1.44%) ▼|ISRG352.63+2.47 (+0.71%) ▲|JNJ267.95-1.17 (-0.43%) ▼|JPM355.39+1.88 (+0.53%) ▲|KO87.79-0.58 (-0.65%) ▼|LIN466.02-2.36 (-0.50%) ▼|LLY1,125.26+1.35 (+0.12%) ▲|LMT526.31-9.84 (-1.84%) ▼|LOW198.71-2.09 (-1.04%) ▼|LRCX314.93-5.50 (-1.71%) ▼|MA569.83-1.06 (-0.19%) ▼|MCD254.55-1.26 (-0.49%) ▼|MDLZ62.28+0.65 (+1.05%) ▲|MDT92.07-0.32 (-0.35%) ▼|META655.08+41.60 (+6.78%) ▲|MMM164.39-3.13 (-1.87%) ▼|MO67.83-0.34 (-0.50%) ▼|MRK147.81-0.65 (-0.44%) ▼|MS215.92-0.32 (-0.15%) ▼|MSFT491.59-2.37 (-0.48%) ▼|MU1,029.05+28.79 (+2.88%) ▲|NEE83.08-0.76 (-0.90%) ▼|NFLX76.13-0.64 (-0.83%) ▼|NKE37.26-0.85 (-2.22%) ▼|NOW131.85-2.36 (-1.76%) ▼|NVDA223.79-1.94 (-0.86%) ▼|ORCL162.64+0.12 (+0.07%) ▲|PEP137.14-1.31 (-0.94%) ▼|PFE27.81+0.02 (+0.07%) ▲|PG142.74-2.84 (-1.95%) ▼|PLTR170.33+0.03 (+0.01%) ▲|PM185.58+0.85 (+0.46%) ▲|QCOM175.42+1.33 (+0.76%) ▲|RTX198.14-0.67 (-0.34%) ▼|SBUX100.60-1.41 (-1.38%) ▼|SCHW106.74-0.14 (-0.13%) ▼|SO88.46-0.54 (-0.60%) ▼|SPG205.58-4.06 (-1.93%) ▼|T25.17-0.43 (-1.68%) ▼|TMO608.81+5.79 (+0.96%) ▲|TMUS177.96-3.73 (-2.05%) ▼|TSLA369.13+0.97 (+0.26%) ▲|TXN260.83+1.91 (+0.74%) ▲|UBER71.30-1.84 (-2.51%) ▼|UNH392.25-8.59 (-2.14%) ▼|UNP285.01-3.44 (-1.19%) ▼|UPS99.44-1.04 (-1.04%) ▼|USB62.26-0.24 (-0.38%) ▼|V368.61-0.03 (-0.01%) ▼|VZ49.76-0.65 (-1.29%) ▼|WFC89.77+1.81 (+2.05%) ▲|WMT105.91-0.14 (-0.13%) ▼|XOM164.05+3.39 (+2.11%) ▲|AAPL315.62-0.60 (-0.19%) ▼|ABBV250.37+1.59 (+0.64%) ▲|ABT105.40-0.12 (-0.11%) ▼|ACN177.31-1.72 (-0.96%) ▼|ADBE255.49-1.78 (-0.69%) ▼|AMAT467.78-5.01 (-1.06%) ▼|AMD519.22+13.48 (+2.67%) ▲|AMGN392.11-1.07 (-0.27%) ▼|AMT175.37-0.37 (-0.21%) ▼|AMZN252.15-4.83 (-1.88%) ▼|AVGO363.76-4.81 (-1.30%) ▼|AXP322.54-3.57 (-1.09%) ▼|BA208.00-2.73 (-1.30%) ▼|BAC62.90+0.51 (+0.81%) ▲|BKNG173.08-7.23 (-4.01%) ▼|BLK1,075.34-20.04 (-1.83%) ▼|BMY64.31-0.39 (-0.60%) ▼|BNY163.26+0.41 (+0.25%) ▲|BRK-B507.31+1.48 (+0.29%) ▲|C138.43+1.69 (+1.23%) ▲|CAT818.05-4.43 (-0.54%) ▼|CL88.02-0.39 (-0.44%) ▼|CMCSA24.56-1.77 (-6.72%) ▼|COF212.55-1.42 (-0.66%) ▼|COP137.24+2.20 (+1.63%) ▲|COST901.49-8.69 (-0.95%) ▼|CRM244.28-4.85 (-1.94%) ▼|CSCO109.28+0.11 (+0.10%) ▲|CVS95.82-0.25 (-0.26%) ▼|CVX214.01+4.21 (+2.01%) ▲|DE677.21-3.53 (-0.52%) ▼|DHR205.08-0.15 (-0.07%) ▼|DIS104.43-0.63 (-0.60%) ▼|DUK120.32-0.92 (-0.76%) ▼|EMR151.08-1.07 (-0.70%) ▼|FDX310.14-3.99 (-1.27%) ▼|GD352.72-3.87 (-1.08%) ▼|GE326.49-8.42 (-2.52%) ▼|GEV953.40-17.91 (-1.84%) ▼|GILD145.74-0.90 (-0.61%) ▼|GM84.75-1.04 (-1.21%) ▼|GOOG328.54-6.85 (-2.04%) ▼|GOOGL330.99-7.38 (-2.18%) ▼|GS1,031.66-4.87 (-0.47%) ▼|HD311.17-2.53 (-0.81%) ▼|HON205.26-2.98 (-1.43%) ▼|IBM239.46+7.37 (+3.18%) ▲|INTC106.23+1.76 (+1.68%) ▲|INTU314.34-4.59 (-1.44%) ▼|ISRG352.63+2.47 (+0.71%) ▲|JNJ267.95-1.17 (-0.43%) ▼|JPM355.39+1.88 (+0.53%) ▲|KO87.79-0.58 (-0.65%) ▼|LIN466.02-2.36 (-0.50%) ▼|LLY1,125.26+1.35 (+0.12%) ▲|LMT526.31-9.84 (-1.84%) ▼|LOW198.71-2.09 (-1.04%) ▼|LRCX314.93-5.50 (-1.71%) ▼|MA569.83-1.06 (-0.19%) ▼|MCD254.55-1.26 (-0.49%) ▼|MDLZ62.28+0.65 (+1.05%) ▲|MDT92.07-0.32 (-0.35%) ▼|META655.08+41.60 (+6.78%) ▲|MMM164.39-3.13 (-1.87%) ▼|MO67.83-0.34 (-0.50%) ▼|MRK147.81-0.65 (-0.44%) ▼|MS215.92-0.32 (-0.15%) ▼|MSFT491.59-2.37 (-0.48%) ▼|MU1,029.05+28.79 (+2.88%) ▲|NEE83.08-0.76 (-0.90%) ▼|NFLX76.13-0.64 (-0.83%) ▼|NKE37.26-0.85 (-2.22%) ▼|NOW131.85-2.36 (-1.76%) ▼|NVDA223.79-1.94 (-0.86%) ▼|ORCL162.64+0.12 (+0.07%) ▲|PEP137.14-1.31 (-0.94%) ▼|PFE27.81+0.02 (+0.07%) ▲|PG142.74-2.84 (-1.95%) ▼|PLTR170.33+0.03 (+0.01%) ▲|PM185.58+0.85 (+0.46%) ▲|QCOM175.42+1.33 (+0.76%) ▲|RTX198.14-0.67 (-0.34%) ▼|SBUX100.60-1.41 (-1.38%) ▼|SCHW106.74-0.14 (-0.13%) ▼|SO88.46-0.54 (-0.60%) ▼|SPG205.58-4.06 (-1.93%) ▼|T25.17-0.43 (-1.68%) ▼|TMO608.81+5.79 (+0.96%) ▲|TMUS177.96-3.73 (-2.05%) ▼|TSLA369.13+0.97 (+0.26%) ▲|TXN260.83+1.91 (+0.74%) ▲|UBER71.30-1.84 (-2.51%) ▼|UNH392.25-8.59 (-2.14%) ▼|UNP285.01-3.44 (-1.19%) ▼|UPS99.44-1.04 (-1.04%) ▼|USB62.26-0.24 (-0.38%) ▼|V368.61-0.03 (-0.01%) ▼|VZ49.76-0.65 (-1.29%) ▼|WFC89.77+1.81 (+2.05%) ▲|WMT105.91-0.14 (-0.13%) ▼|XOM164.05+3.39 (+2.11%) ▲|
28.6 C
New York
Wednesday, September 9, 2026

Tag: study

newssourceFORcompanyinformationcontent1releasesmarket

Global Cancer Immunotherapy Market Projected to Reach $247 Billion by 2029, Driven by 11.4% CAGR

"Harnessing the Power of the Immune System: How Cancer Immunotherapy and Oncolytic Virology Are Reshaping the Future of Oncology in a Digitally Driven Era" BOSTON,...

Press release: Transparency Notification from Shareholders

Transparency Notification from Shareholders

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

VANCOUVER, BC, June 26, 2025 /PRNewswire/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce...

VIZSLA SILVER CLOSES US$100M BOUGHT DEAL OFFERING

VANCOUVER, BC, June 26, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to announce...

Chronic Conditions Surge in U.S. Workforce While Disability Claims Decline, Signaling a New Workforce Health Paradox

OAKLAND, Calif., June 26, 2025 /PRNewswire/ -- More than 78% percent of employees in the US now have at least one chronic condition, an...

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it will host a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8:00 AM ET. For English speakers, please click here to register. For individuals preferring instant Chinese translation, please click here.

STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer

CAMBRIDGE, England, June 26, 2025 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today...

NORTHCLIFF ANNOUNCES PROGRESS REPORT ON PROGRAM TO ADVANCE DEVELOPMENT OF THE SISSON CRITICAL MINERALS PROJECT

VANCOUVER, BC, June 26, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) is pleased to announce that it has engaged...

Scinai Highlights Award-Winning Science Behind PC111 as Key Pincell Researcher Receives “Oscar of Italian Dermatology”

Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the Italian biotech company Pincell srl. JERUSALEM, June 26,...

BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET

PALO ALTO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on Friday, July 11, 2025 at 8:00 am ET with Matthew Wicklund, M.D., FAAN, Professor of Neurology and Vice Chair for Research, Department of Neurology at the University of Texas (UT) Health Science Center San Antonio.

Cellarity Initiates Phase 1 Clinical Study of CLY-124, a First-in-Class Globin-Switching Oral Medicine for the Treatment of Sickle Cell Disease

Initiation follows successful IND clearance based on preclinical data package indicating robust increase in fetal hemoglobin with no cytotoxicity Novel Globin-Switching mechanism derived from...

INTEGRA PROVIDES 2025 GUIDANCE; FOCUSED ON CONSISTENT OPERATIONS AND CAPITAL INVESTMENT AT FLORIDA CANYON AND SIGNIFICANT ADVANCEMENT OF DEVELOPMENT PROJECTS

TSXV: ITR; NYSE American: ITRGwww.integraresources.com VANCOUVER, BC, June 26, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is...

Carbon Credit Market Size Worth 16,379.53 Bn by 2034

According to Precedence Research, the global carbon credit market size is valued at USD 933.23 billion in 2025 and is expected to be worth USD 16,379.53 billion by 2034, growing at a robust CAGR of 37.68% from 2025 to 2034. 
According to Precedence Research, the global carbon credit market size is valued at USD 933.23 billion in 2025 and is expected to be worth USD 16,379.53 billion by 2034, growing at a robust CAGR of 37.68% from 2025 to 2034.

Landmark Study Affirms MolecuLight’s Efficacy in Real-Time Bacterial Detection for Improved Wound Management

TORONTO, June 26, 2025 /PRNewswire/ -- MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, proudly announces the publication of a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStudy

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers